These results provide evidence that the various compounds found in Reishi, which have yet to be isolated, have an inhibitory anti-cancer effect manifested by reduced tumor growth, gene expression, protein synthesis and concomitant inhibition of the mTOR and MAPK pathways showing relevant therapeutic implications in IBC. The gene discussed is MTOR; the disease is neoplasm.